{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:07:26Z","timestamp":1791295646250,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002749","name":"BELSPO","doi-asserted-by":"publisher","award":["P7\/45"],"award-info":[{"award-number":["P7\/45"]}],"id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["PDM\/17\/178"],"award-info":[{"award-number":["PDM\/17\/178"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.antiviral.2017.09.016","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T18:46:47Z","timestamp":1506365207000},"page":"113-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection"],"prefix":"10.1016","volume":"149","author":[{"given":"Rana","family":"Abdelnabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9265-6028","authenticated-orcid":false,"given":"Dirk","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Verbeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8874-675X","authenticated-orcid":false,"given":"Leen","family":"Delang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.09.016_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2015.06.017","article-title":"Towards antivirals against chikungunya virus","volume":"121","author":"Abdelnabi","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.09.016_bib2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/vbz.2014.1681","article-title":"Therapeutics and vaccines against chikungunya virus","volume":"15","author":"Ahola","year":"2015","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"10.1016\/j.antiviral.2017.09.016_bib3","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2017.09.016_bib4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.09.016_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/vbz.2014.1710","article-title":"Chikungunya virus pathogenesis and immunity","volume":"15","author":"Gasque","year":"2015","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.antiviral.2017.09.016_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002614","article-title":"Favipiravir (T-705) inhibits jun\u00edn virus infection and reduces mortality in a Guinea pig model of argentine hemorrhagic fever","volume":"7","author":"Gowen","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2017.09.016_bib7","doi-asserted-by":"crossref","first-page":"13878","DOI":"10.1128\/JVI.02666-13","article-title":"Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response","volume":"87","author":"Hawman","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.09.016_bib8","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.4049\/jimmunol.0900255","article-title":"Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response","volume":"184","author":"Hoarau","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2017.09.016_bib9","first-page":"00709","article-title":"Antiviral activity of Favipiravir (T-705) against a broad range of paramyxoviruses in vitro and against Human Metapneumovirus in hamsters","author":"Jochmans","year":"2016","journal-title":"Antimicrob. Agents Chemother. AAC"},{"key":"10.1016\/j.antiviral.2017.09.016_bib10","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI40104","article-title":"Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages","volume":"120","author":"Labadie","year":"2010","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.antiviral.2017.09.016_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1473-3099(14)71047-3","article-title":"Dose regimen of favipiravir for Ebola virus disease","volume":"15","author":"Mentr\u00e9","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.09.016_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/microbiolspec.EI10-0017-2016","article-title":"Chikungunya virus: current perspectives on a reemerging virus","volume":"4","author":"Morrison","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.antiviral.2017.09.016_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajpath.2010.11.018","article-title":"A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence","volume":"178","author":"Morrison","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2017.09.016_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbrc.2012.07.034","article-title":"Favipiravir (T-705) inhibits in vitro norovirus replication","volume":"424","author":"Rocha-Pereira","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2017.09.016_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2014.01.016","article-title":"Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment","volume":"104","author":"Scharton","year":"2014","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.antiviral.2017.09.016_bib16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/21645515.2015.1101197","article-title":"Chikungunya vaccines in development","volume":"12","author":"Schwameis","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.antiviral.2017.09.016_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.681","article-title":"Chikungunya virus: host pathogen interaction","author":"Singh","year":"2011","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2017.09.016_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004695","article-title":"The viral polymerase inhibitor 7-deaza-2\u2019-C-methyladenosine is a potent inhibitor of in vitro zika virus replication and delays disease progression in a robust mouse infection model","volume":"10","author":"Zmurko","year":"2016","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217304825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217304825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T11:14:13Z","timestamp":1659525253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217304825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":18,"alternative-id":["S0166354217304825"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.09.016","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}